연구성과로 돌아가기
JCR 2024 저널 목록 (1016 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | LIPPINCOTT WILLIAMS & WILKINS | 0268-1315 | 1473-5857 | SCIE | PHARMACOLOGY & PHARMACY | 2,054 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.1 | Q3 | 1.9 | 1.7 | 0.70 | 158/353 | Q2 | 55.38 | 0.001 | 0.221 | 0.557 | Q3 | 42 | 85.7% | 12.3 | 8.0 | 36 | 23.1% | 2025-08-05 16:04:34 | 바로가기 |
| INTERNATIONAL JOURNAL OF BIOMETEOROLOGY | SPRINGER | 0020-7128 | 1432-1254 | SCIE | BIOPHYSICS | 9,701 | 2.6 | Q3 | 51.3 | 48.7 | 41/79 | 3.2 | Q2 | 2.4 | 0.7 | 0.70 | 30/80 | Q2 | 63.13 | 0.005 | 1.072 | 0.661 | Q2 | 225 | 90.7% | 8.5 | 7.5 | 204 | 23.0% | 2025-08-05 16:02:33 | 바로가기 |
| JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN | SPRINGER | 0920-654X | 1573-4951 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 5,790 | 3.1 | Q3 | 51.3 | 48.7 | 164/319 | 3.1 | Q3 | 3.0 | 0.8 | 0.71 | 133/320 | Q2 | 58.59 | 0.002 | 0.436 | 0.695 | Q3 | 35 | 100.0% | 11.8 | 8.6 | 35 | 36.7% | 2025-08-05 16:02:32 | 바로가기 |
| JOURNAL OF MOLECULAR MODELING | SPRINGER | 1610-2940 | 0948-5023 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 9,606 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 2.2 | Q3 | 2.3 | 1.0 | 0.55 | 108/241 | Q2 | 55.39 | 0.005 | 1.039 | 0.319 | Q3 | 420 | 98.8% | 6.8 | 9.1 | 415 | 4.9% | 2025-08-05 16:02:40 | 바로가기 |
| Journal of Natural Medicines | SPRINGER JAPAN KK | 1340-3443 | 1861-0293 | SCIE | PHARMACOLOGY & PHARMACY | 3,488 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.9 | Q2 | 2.2 | 0.8 | 0.69 | 164/353 | Q2 | 53.68 | 0.002 | 0.379 | 0.437 | Q3 | 90 | 93.3% | 6.8 | 7.4 | 84 | 14.4% | 2025-08-05 16:04:34 | 바로가기 |
| Journal of Pharmaceutical Policy and Practice | TAYLOR & FRANCIS LTD | N/A | 2052-3211 | ESCI | PHARMACOLOGY & PHARMACY | 1,630 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 3.0 | Q2 | 2.3 | 0.5 | 0.88 | 97/353 | Q2 | 72.66 | 0.002 | 0.518 | 0.686 | Q2 | 130 | 91.5% | 3.3 | 5.7 | 119 | 99.7% | 2025-08-05 16:04:34 | 바로가기 |
| JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION | ELSEVIER | 1544-3191 | 1544-3450 | SCIE | PHARMACOLOGY & PHARMACY | 4,071 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.2 | Q3 | 2.1 | 0.8 | 0.63 | 189/353 | Q3 | 46.60 | 0.005 | 1.026 | 0.593 | Q3 | 232 | 94.0% | 4.7 | 6.2 | 218 | 7.7% | 2025-08-05 16:04:34 | 바로가기 |
| MARINE CHEMISTRY | ELSEVIER | 0304-4203 | 1872-7581 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 9,364 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 2.9 | Q2 | 2.3 | 0.4 | 0.65 | 95/241 | Q2 | 60.79 | 0.002 | 0.555 | 0.837 | Q2 | 76 | 100.0% | 17.5 | 11.8 | 76 | 24.8% | 2025-08-05 16:02:40 | 바로가기 |
| NEW JOURNAL OF CHEMISTRY | ROYAL SOC CHEMISTRY | 1144-0546 | 1369-9261 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 50,872 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 2.7 | Q2 | 2.4 | 0.7 | 0.47 | 122/241 | Q3 | 49.59 | 0.032 | 7.206 | 0.360 | Q3 | 1913 | 99.4% | 4.9 | 5.8 | 1902 | 4.0% | 2025-08-05 16:02:40 | 바로가기 |
| PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | TAYLOR & FRANCIS LTD | 1083-7450 | 1097-9867 | SCIE | PHARMACOLOGY & PHARMACY | 3,836 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.8 | Q2 | 2.4 | 0.7 | 0.72 | 150/353 | Q2 | 57.65 | 0.002 | 0.378 | 0.389 | Q3 | 100 | 83.0% | 6.9 | 6.7 | 83 | 6.4% | 2025-08-05 16:04:34 | 바로가기 |
| PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | PERGAMON-ELSEVIER SCIENCE LTD | 0091-3057 | 1873-5177 | SCIE | PHARMACOLOGY & PHARMACY | 9,945 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 3.1 | Q2 | 2.4 | 0.4 | 0.83 | 110/353 | Q2 | 68.98 | 0.004 | 0.923 | 0.867 | Q2 | 147 | 87.1% | 14.9 | 10.9 | 128 | 14.2% | 2025-08-05 16:04:33 | 바로가기 |
| Physical Chemistry Research | IRANIAN CHEMICAL SOC | 2322-5521 | 2345-2625 | ESCI | CHEMISTRY, MULTIDISCIPLINARY | 669 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 1.7 | Q3 | 2.1 | 1.3 | 0.34 | 144/241 | Q3 | 40.46 | 0.000 | 0.072 | 0.173 | Q3 | 80 | 100.0% | 3.2 | 7.8 | 80 | 0.0% | 2025-08-05 16:02:40 | 바로가기 |
| RSC Chemical Biology | ROYAL SOC CHEMISTRY | 2633-0679 | 2633-0679 | ESCI | BIOCHEMISTRY & MOLECULAR BIOLOGY | 1,580 | 3.1 | Q3 | 51.3 | 48.7 | 164/319 | 3.9 | Q2 | 3.0 | 0.6 | 0.55 | 212/320 | Q3 | 33.91 | 0.003 | 0.771 | 1.139 | Q2 | 110 | 86.4% | 3.1 | 8.2 | 95 | 100.0% | 2025-08-05 16:02:32 | 바로가기 |
| SCIENTIA PHARMACEUTICA | MDPI | N/A | 2218-0532 | ESCI | PHARMACOLOGY & PHARMACY | 2,037 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 3.3 | Q2 | 2.5 | 0.5 | 0.68 | 170/353 | Q2 | 51.98 | 0.001 | 0.211 | 0.451 | Q3 | 68 | 79.4% | 7.0 | 7.7 | 54 | 100.0% | 2025-08-05 16:04:34 | 바로가기 |
| Advances in Nano Research | TECHNO-PRESS | 2287-237X | 2287-2388 | SCIE | MATERIALS SCIENCE, MULTIDISCIPLINARY | 1,670 | 3.2 | Q3 | 51.4 | 48.6 | 237/460 | 3.6 | Q2 | 2.3 | 1.0 | 0.62 | 212/462 | Q2 | 54.22 | 0.001 | 0.238 | 0.360 | Q3 | 95 | 99.0% | 3.4 | 5.1 | 94 | 0.0% | 2025-08-05 16:03:57 | 바로가기 |
페이지 이동: